158 related articles for article (PubMed ID: 33242396)
1. Recessive, Deleterious Variants in SMG8 Expand the Role of Nonsense-Mediated Decay in Developmental Disorders in Humans.
Alzahrani F; Kuwahara H; Long Y; Al-Owain M; Tohary M; AlSayed M; Mahnashi M; Fathi L; Alnemer M; Al-Hamed MH; Lemire G; Boycott KM; Hashem M; Han W; Al-Maawali A; Al Mahrizi F; Al-Thihli K; Gao X; Alkuraya FS
Am J Hum Genet; 2020 Dec; 107(6):1178-1185. PubMed ID: 33242396
[TBL] [Abstract][Full Text] [Related]
2. Expanding the phenotypic and allelic spectrum of SMG8: Clinical observations reveal overlap with SMG9-associated disease trait.
Abdel-Salam GMH; Duan R; Abdel-Hamid MS; Sayed ISM; Jhangiani SN; Khan Z; Du H; Gibbs RA; Posey JE; Marafi D; Lupski JR
Am J Med Genet A; 2022 Feb; 188(2):648-657. PubMed ID: 34761517
[TBL] [Abstract][Full Text] [Related]
3. Cryo-EM structure of SMG1-SMG8-SMG9 complex.
Zhu L; Li L; Qi Y; Yu Z; Xu Y
Cell Res; 2019 Dec; 29(12):1027-1034. PubMed ID: 31729466
[TBL] [Abstract][Full Text] [Related]
4. Mutations in SMG9, Encoding an Essential Component of Nonsense-Mediated Decay Machinery, Cause a Multiple Congenital Anomaly Syndrome in Humans and Mice.
Shaheen R; Anazi S; Ben-Omran T; Seidahmed MZ; Caddle LB; Palmer K; Ali R; Alshidi T; Hagos S; Goodwin L; Hashem M; Wakil SM; Abouelhoda M; Colak D; Murray SA; Alkuraya FS
Am J Hum Genet; 2016 Apr; 98(4):643-52. PubMed ID: 27018474
[TBL] [Abstract][Full Text] [Related]
5. Confirmation and further delineation of the SMG9-deficiency syndrome, a rare and severe developmental disorder.
Lecoquierre F; Bonnevalle A; Chadie A; Gayet C; Dumant-Forest C; Renaux-Petel M; Leca JB; Hazelzet T; Brasseur-Daudruy M; Louillet F; Muraine M; Coutant S; Quenez O; Boland A; Deleuze JF; Frebourg T; Goldenberg A; Saugier-Veber P; Guerrot AM; Nicolas G
Am J Med Genet A; 2019 Nov; 179(11):2257-2262. PubMed ID: 31390136
[TBL] [Abstract][Full Text] [Related]
6. Structures of SMG1-UPFs complexes: SMG1 contributes to regulate UPF2-dependent activation of UPF1 in NMD.
Melero R; Uchiyama A; Castaño R; Kataoka N; Kurosawa H; Ohno S; Yamashita A; Llorca O
Structure; 2014 Aug; 22(8):1105-1119. PubMed ID: 25002321
[TBL] [Abstract][Full Text] [Related]
7. Structure of a SMG8-SMG9 complex identifies a G-domain heterodimer in the NMD effector proteins.
Li L; Lingaraju M; Basquin C; Basquin J; Conti E
RNA; 2017 Jul; 23(7):1028-1034. PubMed ID: 28389433
[TBL] [Abstract][Full Text] [Related]
8. A novel variant in SMG9 causes intellectual disability, confirming a role for nonsense-mediated decay components in neurocognitive development.
Rahikkala E; Urpa L; Ghimire B; Topa H; Kurki MI; Koskela M; Airavaara M; Hämäläinen E; Pylkäs K; Körkkö J; Savolainen H; Suoranta A; Bertoli-Avella A; Rolfs A; Mattila P; Daly M; Palotie A; Pietiläinen O; Moilanen J; Kuismin O
Eur J Hum Genet; 2022 May; 30(5):619-627. PubMed ID: 35087184
[TBL] [Abstract][Full Text] [Related]
9. Cryo-EM reconstructions of inhibitor-bound SMG1 kinase reveal an autoinhibitory state dependent on SMG8.
Langer LM; Bonneau F; Gat Y; Conti E
Elife; 2021 Oct; 10():. PubMed ID: 34698635
[TBL] [Abstract][Full Text] [Related]
10. CK2-mediated TEL2 phosphorylation augments nonsense-mediated mRNA decay (NMD) by increase of SMG1 stability.
Ahn S; Kim J; Hwang J
Biochim Biophys Acta; 2013 Oct; 1829(10):1047-55. PubMed ID: 23831331
[TBL] [Abstract][Full Text] [Related]
11. The RNA helicase DHX34 functions as a scaffold for SMG1-mediated UPF1 phosphorylation.
Melero R; Hug N; López-Perrote A; Yamashita A; Cáceres JF; Llorca O
Nat Commun; 2016 Feb; 7():10585. PubMed ID: 26841701
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel compound heterozygous SMG9 variants in a Chinese family with heart and brain malformation syndrome using whole exome sequencing.
Yang Q; Qin Z; Zhang Q; Yi S; Yi S; Luo J
BMC Med Genomics; 2022 Mar; 15(1):67. PubMed ID: 35321723
[TBL] [Abstract][Full Text] [Related]
13. Identifying Cellular Nonsense-Mediated mRNA Decay (NMD) Targets: Immunoprecipitation of Phosphorylated UPF1 Followed by RNA Sequencing (p-UPF1 RIP-Seq).
Kurosaki T; Hoque M; Maquat LE
Methods Mol Biol; 2018; 1720():175-186. PubMed ID: 29236259
[TBL] [Abstract][Full Text] [Related]
14. Conservation of Nonsense-Mediated mRNA Decay Complex Components Throughout Eukaryotic Evolution.
Causier B; Li Z; De Smet R; Lloyd JPB; Van de Peer Y; Davies B
Sci Rep; 2017 Nov; 7(1):16692. PubMed ID: 29192227
[TBL] [Abstract][Full Text] [Related]
15. Juggling key players in NMD initiation.
Bono F
Structure; 2014 Aug; 22(8):1074-1075. PubMed ID: 25099951
[TBL] [Abstract][Full Text] [Related]
16. Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders.
Nguyen LS; Kim HG; Rosenfeld JA; Shen Y; Gusella JF; Lacassie Y; Layman LC; Shaffer LG; Gécz J
Hum Mol Genet; 2013 May; 22(9):1816-25. PubMed ID: 23376982
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Nonsense-Mediated Decay Induces Nociceptive Sensitization through Activation of the Integrated Stress Response.
de la Peña JB; Chase R; Kunder N; Smith PR; Lou TF; Stanowick A; Suresh P; Shukla T; Butcher SE; Price TJ; Campbell ZT
J Neurosci; 2023 Apr; 43(16):2921-2933. PubMed ID: 36894318
[TBL] [Abstract][Full Text] [Related]
18. Defining nonsense-mediated mRNA decay intermediates in human cells.
Kurosaki T; Myers JR; Maquat LE
Methods; 2019 Feb; 155():68-76. PubMed ID: 30576707
[TBL] [Abstract][Full Text] [Related]
19. Structure of substrate-bound SMG1-8-9 kinase complex reveals molecular basis for phosphorylation specificity.
Langer LM; Gat Y; Bonneau F; Conti E
Elife; 2020 May; 9():. PubMed ID: 32469312
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of the RNA helicase UPF1 involved in nonsense-mediated mRNA decay.
Fiorini F; Bonneau F; Le Hir H
Methods Enzymol; 2012; 511():255-74. PubMed ID: 22713324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
